Development of Polygenic Risk Scores in Colon Cancer Patients Through the Study of Ancestry and Diversity in Genetic Maps of the Brazilian Population - ORIGEM Project
NCT ID: NCT06917794
Last Updated: 2025-04-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
500 participants
OBSERVATIONAL
2025-03-14
2027-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genetic Analysis to Evaluate the Racial Difference in the Outcome of Patients With Colon Cancer
NCT01479894
Oligogenic Determinism of Colorectal Cancer
NCT01057953
Implication of Genetic Variations in Long Intergenic Non-coding RNA 00511 (LINC00511) in Colorectal Cancer
NCT06534242
Genetic Variants of Selected Genes in Colo-Rectal Cancer Patients.
NCT02542670
Characterization of Brazilian Colorectal Cancer Screening Population
NCT03355391
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For individuals with certain hereditary cancer syndromes, the risk of developing colorectal cancer can reach 50-80% in the absence of endoscopic and/or surgical intervention. Therefore, characterizing high-, moderate-, and low-penetrance genes within a population is crucial for understanding hereditary tumorigenesis and guiding more cost-effective screening strategies.
Genetic studies comparing genomes from populations of different ethnic backgrounds have demonstrated that ancestry plays a significant role in genetic predisposition to CRC. Given the high level of genetic admixture in the Brazilian population, studies focused solely on populations of European ancestry fail to provide a representative model for application in highly admixed populations like Brazil.
In this context, the present study aims to utilize next-generation sequencing (NGS) in a cohort representative of the Brazilian population with CRC and controls to develop a Polygenic Risk Score (PRS). This score could impact cancer screening and prevention strategies, as well as genetic counseling for patients and their families. The hypothesis is that genetic mapping-including ancestry, germline, and tumor genetic variability-in Brazilian colorectal cancer patients will provide valuable data for developing a PRS that may eventually guide more targeted and cost-effective screening strategies for our population.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Histologically confirmed diagnosis of colorectal cancer;
* Have available tumor material for somatic sequencing, obtained from biopsy or routine surgery;
* Sign the informed consent form (ICF) for the study.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
D'Or Institute for Research and Education
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rodrigo Santa Cruz Guindalini
Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Instituto D'Or de Pesquisa e Ensino
Fortaleza, Ceará, Brazil
CPOC - Centro de Pesquisa Oncológica e Clínica, faz parte do Complexo Associação Obras Sociais lrmã Dulce (AOSID)
Salvador, Estado de Bahia, Brazil
Instituto D'Or de Pesquisa e Ensino
Salvador, Estado de Bahia, Brazil
Instituto D'Or de Pesquisa e Ensino
Brasília, Federal District, Brazil
Instituto D'Or de Pesquisa e Ensino
Curitiba, Paraná, Brazil
Instituto D'Or de Pesquisa e Ensino
Recife, Pernambuco, Brazil
Instituto D'Or de Pesquisa e Ensino
Rio de Janeiro, Rio de Janeiro, Brazil
Instituto D'Or de Pesquisa e Ensino
São Paulo, São Paulo, Brazil
Instituto do Câncer do Estado de São Paulo
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
25000.130491/2023-48 - ORIGEM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.